Coronavirus: Vaccination

Department of Health and Social Care written question – answered on 14th July 2021.

Alert me about debates like this

Photo of Helen Hayes Helen Hayes Labour, Dulwich and West Norwood

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of covid-19 vaccines for people living with blood cancer.

Photo of Nadhim Zahawi Nadhim Zahawi Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy), The Parliamentary Under-Secretary for Health and Social Care

Virus Watch, supported by NHS Test and Trace, provides information regarding patients’ antibodies and this includes immunocompromised patients, such as those living with blood cancer as part of their cohort. The data suggests some protection against COVID-19.

Public Health England is monitoring the effectiveness of vaccinations in clinical risk groups which will include those with immunosuppression. From the evaluation of the vaccine programme, the data shows that completion of the two dose schedule correlates well with protection from both disease and severe outcomes, including hospitalisation and death.

The Joint Committee on Vaccination and Immunisation (JCVI) has issued interim advice about a potential COVID-19 booster programme from September 2021, starting with those most at risk from serious disease. This will include clinically extremely vulnerable adults and those who are immunosuppressed. The JCVI will continue to review evidence on the use of vaccines in those with immunosuppression and will update its advice as necessary.

Does this answer the above question?

Yes2 people think so

No2 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.